Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuro-immunology
Can you use a JAK inhibitor and Mavenclad in a patient with both multiple sclerosis and rheumatoid arthritis?
Related Questions
When do you start cyclophosphamide for the treatment of anti-NMDA receptor encephalitis?
How do you counsel patients who experience diarrhea from mycophenolate mofetil (Cellcept)?
Should IVIg dosing in patients with autoimmune disease (i.e., dermatomyositis) who become pregnant continue to be based on actual weight at the time of each infusion, or should it be limited to pre-pregnancy weight?
What is your initial treatment paradigm for someone with both CNS and peripheral neurologic Sjogren’s?
How do you interpret the results of oligoclonal bands ordered to evaluate for demyelinating disease in patients with brain MRI lesions of unclear etiology?
Do you see a current or future clinical role of neurofilament light chain in the diagnosis or workup of multiple sclerosis?
What is your approach to immune management in opsoclonus-myoclonus-ataxia syndrome?
For patients on anti-CD20 therapy for MS without frequent/opportunistic infections, are there serum IgG levels or ALC levels in which you pause or change therapy due to low levels?
How would you manage a patient with LGI-1 encephalitis with faciobracial dystonic seizures who has not improved with 3 days of intravenous steroids?
How do you approach managing nausea and GI side effects when initiating methotrexate?
